EUVIMEDEUVIMED entdecken
Crossref

Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury

Wenjia Zhang iD, Junxia Zhang iD, Zeyuan Wang iD, Ting Li iD, Changyun Liu iD, Xuya Kang iD, Xiaomeng Cui, Jingli Yang iD, Huilin Qu, Jiaxin Duanmu, Ying Peng, Kai Wang iD und 21 weitere

Circulation · 26.11.2024 · 150 (22) · 1791-1811

DOI: 10.1161/circulationaha.123.068595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 26.11.2024. Verfasst von Wenjia Zhang und 32 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center (W. Zhang, J.Z., C.L., X.K., X.C., J.…. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Myocardial Reperfusion Injury. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 89 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cardiac ischemia/reperfusion (I/R) injury has emerged as an important therapeutic target for ischemic heart disease. Currently, there is no effective therapy for reducing cardiac I/R injury. Damage-associated molecular patterns are endogenous molecules released after cellular damage to exaggerate tissue inflammation and injury. RIPK3 (receptor-interacting protein kinase 3), a well-established intracellular mediator of cell necroptosis and inflammation, serves as a circulating biomarker of multiple diseases. However, whether extracellular RIPK3 also exerts biological functions in cardiac I/R injury remains totally unknown. METHODS: Patients with acute myocardial infarction receiving percutaneous coronary intervention (PCI) were recruited independently in the discovery cohort (103 patients) and validation cohort (334 patients), and major adverse cardiovascular events were recorded. Plasma samples were collected before and after PCI (6 and 24 h) for RIPK3 concentration measurement. Cultured neonatal rat ventricular myocytes, macrophages and endothelial cells, and in vivo mouse models with myocardial injury induced by I/R (or hypoxia/reoxygenation) were used to investigate the role and mechanisms of extracellular RIPK3. Another cohort including patients with acute myocardial infarction receiving PCI and healthy volunteers was recruited to further explore the mechanisms of extracellular RIPK3. RESULTS: In the discovery cohort, elevated plasma RIPK3 levels after PCI are associated with poorer short- and long-term outcomes in patients with acute myocardial infarction, as confirmed in the validation cohort. In both cultured cells and in vivo mouse models, recombinant RIPK3 protein exaggerated myocardial I/R (or hypoxia/reoxygenation) injury, which was alleviated by the RIPK3 antibody. Mechanistically, RIPK3 acted as a damage-associated molecular pattern and bound with RAGE (receptor of advanced glycation end-products), subsequently activating CaMKII (Ca 2+ /calmodulin-dependent kinase II) to elicit the detrimental effects. The positive correlation between plasma RIPK3 concentrations and CaMKII phosphorylation in human peripheral blood mononuclear cells was confirmed. CONCLUSIONS: We identified the positive relationship between plasma RIPK3 concentrations and the risk of major adverse cardiovascular events in patients with acute myocardial infarction receiving PCI. As a damage-associated molecular pattern, extracellular RIPK3 plays a causal role in multiple pathological conditions during cardiac I/R injury through RAGE/CaMKII signaling. These findings expand our understanding of the physiological and pathological roles of RIPK3, and also provide a promising therapeutic target for myocardial I/R injury and the associated complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor-Interacting Protein Serine-Threonine KinasesMyocardial Reperfusion InjuryHumansAnimalsMaleMiddle AgedFemaleMiceRatsAgedMyocytes, CardiacMice, Inbred C57BLMyocardial InfarctionPercutaneous Coronary InterventionBiomarkersDisease Models, AnimalRats, Sprague-Dawley

Stichwörter der Autor:innen

CaMKIIdamage-associated molecular patternheartischemia/reperfusion injuryreceptor-interacting protein kinase 3

Substanzen

Receptor-Interacting Protein Serine-Threonine KinasesRIPK3 protein, humanRipk3 protein, mouseBiomarkers

Autor:innen und Institutionen

  • Institute of Cardiovascular Sciences, School of Basic Medical Sciences, Peking University Health Science Center (W. Zhang, J.Z., C.L., X.K., X.C., J.Y, H.Q., J.D., Y. Liu, Y. Li, E.D., Y.Z).
  • Department of Cardiology and Institute of Vascular Medicine (W. Zhang, J.Z., C.L., X.K., X.C., J.Y., H.Q., J.D., Y. Liu, Y. Li, E.D., Y.Z.).
  • Peking University Third Hospital, State Key Laboratory of Vascular Homeostasis and Remodeling (W. Zhang, J.Z., C.L., X.K., X.C., J.Y., H.Q., J.D, Y. Liu, Y. Li, E.D., Y.Z.).
  • Research Unit of Medical Science Research Management/Basic and Clinical Research of Metabolic Cardiovascular Diseases, Chinese Academy of Medical Sciences, Haihe Laboratory of Cell Ecosystem, Beijing (J.Z., E.D.).
  • Department of Cardiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing (Z.W., Z.T., Z.L., Y…
  • Department of Cardiology, First Affiliated Hospital, Xi'an Jiaotong University, China (T.L., X.Z., Y.W.).

ORCID-Profile: Wenjia Zhang, Junxia Zhang, Zeyuan Wang, Ting Li, Changyun Liu, Xuya Kang, Jingli Yang, Kai Wang, Zhuang Tian, Zhenyu Liu, Nan Li, Xiaozhen Zhuo, Yue Wu, Xiaolu Shi, Yueshen Sun, Kai Zhang, Erdan Dong, Yan Zhang

Zitieren

APA

Zhang, W., Zhang, J., Wang, Z., Li, T., Liu, C., Kang, X., Cui, X., Yang, J., Qu, H., Duanmu, J., Peng, Y., Wang, K., Jin, L., Xie, P., Zheng, W., Shang, H., Liu, Y., Tian, Z., Liu, Z., …, & Zhang, Y. (2024). Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury. Circulation, 150(22), 1791-1811. https://doi.org/10.1161/circulationaha.123.068595

Vancouver

Zhang W, Zhang J, Wang Z, Li T, Liu C, Kang X, et al. Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury. Circulation. 2024;150(22):1791-1811. doi:10.1161/circulationaha.123.068595

BibTeX
@article{Zhang2024,
  author = {Zhang, Wenjia and Zhang, Junxia and Wang, Zeyuan and Li, Ting and Liu, Changyun and Kang, Xuya and Cui, Xiaomeng and Yang, Jingli and Qu, Huilin and Duanmu, Jiaxin and Peng, Ying and Wang, Kai and Jin, Li and Xie, Peng and Zheng, Wen and Shang, Haibao and Liu, Yahan and Tian, Zhuang and Liu, Zhenyu and Jin, Ye and Li, Yingjia and Li, Nan and Zhuo, Xiaozhen and Wu, Yue and Shi, Xiaolu and Ma, Runhao and Sun, Yueshen and Zhang, Kai and Fang, Xiangming and Hu, Xiaomin and Dong, Erdan and Zhang, Shuyang and Zhang, Yan},
  title = {Extracellular RIPK3 Acts as a Damage-Associated Molecular Pattern to Exaggerate Cardiac Ischemia/Reperfusion Injury},
  journal = {Circulation},
  year = {2024},
  volume = {150},
  number = {22},
  pages = {1791--1811},
  doi = {10.1161/circulationaha.123.068595}
}
Kostenlos starten →